Please use this identifier to cite or link to this item:
Title: Pharmacoeconomics of Orphan Disease Treatment with a Focus on Hereditary Angioedema
Authors: Lumry, William R.
Year: 2017
Publisher: Elsevier Inc
Abstract: This article discusses orphan diseases, their prevalence, legislative incentives to encourage development of therapies, and the impact of treatment on health care payment systems. Specifically, the cost burden of hereditary angioedema on patients, health care systems, and society is reviewed. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and overall burden of disease is explored. Changes in treatment paradigms to improve effect and reduce cost of treatment are presented.
volume: Volume 37
issue: Issue 3
month: August
Appears in Collections:Immunology and Allergy Clinics of North America 2017

Files in This Item:
File Description SizeFormat 
2017 IACNA Volume 37 Issue 3 August (4).pdf198.54 kBAdobe PDFThumbnail
Download    Request a copy

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.